Drug class
Kinase Inhibitor
22 drugs the FDA files under Kinase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- BosutinibKinase Inhibitor$16,110.00Cost Plus Drugs
- Erlotinib · 3 strengths and formsKinase Inhibitor$35.94Cost Plus Drugs
- Everolimus · 11 strengths and formsKinase Inhibitor$38.18Cost Plus Drugs
- GefitinibKinase Inhibitor$1,158.85Cost Plus Drugs
- Nilotinib · 3 strengths and formsKinase Inhibitor$53.13Cost Plus Drugs
- PazopanibKinase Inhibitor$287.44Cost Plus Drugs
- RemibrutinibKinase Inhibitor
- SorafenibKinase Inhibitor$436.68Cost Plus Drugs
Cheapest option we hold for the usual fill, fees included, checked November 4, 2026. Open a medicine for every option and the date on each one.